These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19838028)

  • 1. [Efficacy and safety of continuous subcutaneous injection of the compound oxycodone in cancer pain management: the first 4-year audit].
    Yoshimoto T; Hisada A; Hasegawa T; Nozaki Y; Matoba M;
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1683-9. PubMed ID: 19838028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of compound oxycodone injection for cancer pain relief-a multicenter survey of prescriptions].
    Yoshimoto T; Hisada A; Yomiya K; Tomiyasu S; Hasegawa T; Murakami S; Matoba M
    Gan To Kagaku Ryoho; 2010 May; 37(5):871-8. PubMed ID: 20495318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective study on intravenous compound injection of cancer pain patients with oxycodone and hydrocotarnine preparation in comparison with subcutaneous administration].
    Sano T; Akagi T; Yokote N; Shuto C; Kudo N; Miura K; Murakami S; Saito O; Yamamoto H; Matoba M
    Gan To Kagaku Ryoho; 2012 May; 39(5):769-75. PubMed ID: 22584329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conversion ratio between intravenous oxycodone/hydrocotarnine and sustained-release oral oxycodone in patients with cancer pain].
    Kokubun H; Nakamura K; Fukawa M; Matoba M; Hoka S; Yago K
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2255-8. PubMed ID: 18079625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.
    Tessaro L; Bandieri E; Costa G; Fornasier G; Iorno V; Pizza C; Pastacaldi G; Micheletto G
    Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):113-21. PubMed ID: 20329570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three-day-type transdermal fentanyl patch conversion by rapid titration method with short-acting oral oxycodone for cancer pain].
    Yamazaki K; Fujio N; Ishikawa N; Watanabe H; Kameyama M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):405-8. PubMed ID: 22421768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oxycodone in polytrauma patients: the "Gemelli" experience.
    Franceschi F; Marini M; Ursella S; Carbone L; Candelli M; Pignataro G; Gabrielli M; Santarelli L; Ojetti V; Giupponi B; Fiore V; Barbaro F; De Marco G; Buccelletti F; Mancini F; Roccarina D; Gigante G; Gasbarrini A; Gasbarrini G; Silveri NG
    Eur Rev Med Pharmacol Sci; 2008; 12(2):123-6. PubMed ID: 18575163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.
    Suzuki T; Morishita M; Ito E; Matsuura M; Tanaka R; Saito T
    Am J Ther; 2008; 15(1):31-5. PubMed ID: 18223351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR; Moore J; Gray RO; Skinner L; Biros MH
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
    Yu SY;
    Oncology; 2008; 74 Suppl 1():46-51. PubMed ID: 18758197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer].
    Ikeda M; Sonoo H; Kurebayashi J; Oota Y; Fujii S; Shimo T; Mizutou A; Seki M; Saitou W; Yamashita T; Koike Y; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K; Nomura T; Kubo S
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):599-603. PubMed ID: 22504685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral oxycodone: new preparation. No better than oral morphine.
    Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of 31 terminally ill cancer patients who received pure oxycodone injections at home].
    Sasaki T; Kawagoe I
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1397-400. PubMed ID: 25434442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
    Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P
    Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three cases of cancer-related pain for which oxycodone injection was efficacious].
    Shinozaki K; Nitta T; Yamauchi M; Doi M
    Gan To Kagaku Ryoho; 2013 Jan; 40(1):119-23. PubMed ID: 23306933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in patients with terminally ill cancer: a retrospective study.
    Kawabata M; Kaneishi K
    Am J Hosp Palliat Care; 2013 May; 30(3):305-11. PubMed ID: 22669937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.